Press release
MakroCare awarded a large cancer registry program a promising US biotech company
The objective of this registry is to collect real-world data focusing on treatment decision impact, outcomes in the management of cancer patients and clinical utilization of the diagnostic platform in various cancer patients. This multicenter, non-randomized, single arm, real-world data collection registry is expected to enroll around 1500+ patients over next several years. Some of the key outcomes of this registry would be clinical utilization pattern, treatment-decision impact, clinical benefits rate and objective response rate.
As RWE and outcomes research are becoming increasingly important and necessary for product development and commercialization, MakroCare brings to table technology integrated, cost efficient, non-traditional solutions to support companies in this space.
MakroCare is a leading biotech, pharma and medical device consulting for Clinical Development, Regulatory affairs, Regulatory Operation, Publishing, Labeling, Med Affairs, Central Monitoring and RBM services.
650 College Road East ,Suite 3600 , Princeton, NJ -08540-US
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MakroCare awarded a large cancer registry program a promising US biotech company here
News-ID: 694339 • Views: …
More Releases from MakroCare
Global TOP 5 Pharma Company awarded Regulatory Digitization to MakroCare
Recognizing the unique benefit MakroCare brings in combining functional expertise with technology, a global TOP 5 Pharma selected MakroCare for their strategic regulatory transformation program. In order to support them for next several years to come in various regulatory areas, this digitization and centralization initiatives taken up by this client.
MakroCare combined Regulatory / CMC functional expertise with proprietary technology to digitize last 3 decades of legacy dossiers and extract meaningful…
A Global TOP 10 Medical Device Company Selected MakroCare
MakroCare got selected by a global Top 10 medical device company for upcoming MDR and Rev 4 compliance program. With major changes anticipated for upcoming MDR, this global company knew well an external partner who can align well with their overall goals to help them meet short and long-term goals is vital for their strategy. To start with, to meet current compliance needs of Rev 4 clinical evaluation, a set…
More Releases for RWE
Wood-Pellets Market Expected to Reach Nearly USD 9.0 Billion by 2031 | RWE Innog …
QYResearch A newly published report titled "Global Wood-Pellets Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Wood-Pellets market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and…
U.S. Real-World Evidence (RWE) Solutions Market - Forecast to 2029
Meticulous Research®- leading U.S. market research company published a research report titled "U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029."
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5243
According to this latest publication from Meticulous Research®, the U.S. real-world evidence (RWE) solutions market is expected to grow at a CAGR of 13.1%…
Real-world Evidence (RWE) Analytics Market Worth $2.93 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'RWE Analytics Market by Application [Market Access & Reimbursement, Drug Development & Approval (Oncology, Neurology, Cardiovascular), Post Market Surveillance, Medical Device Development], End User (Pharma, Payer, Provider) - Global Forecast to 2029'.
Access Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5306
According to this latest publication from Meticulous Research®, the global real-world evidence (RWE) analytics market is expected to grow…
Sales of Real World Evidence/RWE Solutions Industry by 2031 | GIS
Global Real World Evidence/RWE Solutions Market report from Global Insight Services is the single authoritative source of intelligence on Real World Evidence/RWE Solutions Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data…
Real-World Evidence (RWE) Oncology Market Worth $1.65 Billion by 2029
According to a new market research report titled, 'RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), and End User (Pharma, Payer) - Global Forecast to 2029,' published by Meticulous Research®, the real-world evidence oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029.
Download Free Sample Report…
Nuclear Power Plant Market Next Big Thing | Kepco, Magnox, RWE, Entergy
Nuclear power plant (NPP) uses nuclear fission reaction to heat water to produce steam which runs the turbines to generate electricity. The fission process occurs inside the reactor where uranium fuel is stored in its core. Considering the high fuel to output ratio produced by these power plants, countries are heavily investing in development of nuclear power plant. United States accounts for 20% of their total electricity production through nuclear…
